Form D — Syncromune, Inc.
0001231919-26-000472 · filed 2026-05-11
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $144,828,791
- Total sold
- $144,828,791
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Syncromune, Inc.
- CIK
- 1955312
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2919 E. COMMERCIAL BLVD., SUITE 200
FORT LAUDERDALE, FL 33308 - Phone
- 518-796-6110
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Charles J. Link · Executive OfficerFort Lauderdale, FL Find on LinkedIn ↗
-
Eamonn Hobbs · Executive OfficerFort Lauderdale, FL Find on LinkedIn ↗
-
Joseph Gerardi · Executive OfficerFort Lauderdale, FL Find on LinkedIn ↗
-
Agustin Gago · Executive OfficerFort Lauderdale, FL Find on LinkedIn ↗
-
Joseph C. Maroon · DirectorFort Lauderdale, FL Find on LinkedIn ↗
-
Douglas G. Watson · DirectorFort Lauderdale, FL Find on LinkedIn ↗
-
Jeffrey L. Cleland · DirectorFort Lauderdale, FL Find on LinkedIn ↗
-
Norman Schwartz · DirectorFort Lauderdale, FL Find on LinkedIn ↗
-
Kerri-Ann Millar · Executive OfficerFort Lauderdale, FL Find on LinkedIn ↗
-
Stephen Dale · Executive OfficerFort Lauderdale, FL Find on LinkedIn ↗
View original on SEC EDGAR.